Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Genomics Market: By Product: Consumables, Systems and Software, Services; By Technology: PCR, Sequencing, Microarray, Others; By Application; By End User; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Genomics Market Outlook
The global genomics market was estimated at USD 16.21 billion in 2020 and is expected to grow at a CAGR of 9.3% over the forecast period of 2021-2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market for genomics is driven by the genomic data pool, which has resulted in the development of the study operations, allowing physicians, biologists, and patients to further explore the genetic predisposition to certain illnesses. It is anticipated that the clinical implementation of this data pool will play a significant part in transforming the healthcare system with regard to providing more precise, efficient, and reliable alternatives for disease management.
Global Genomics Market: Properties and Applications
Genomics is referred to as the branch of molecular biology concerned with the structure, function, evolution, and mapping of genomes.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The genomics market can be divided based on segments like product, technology, application, and end-use.
The genomics industry is broadly divided on the basis of product into:
- Consumables
- Systems and Software
- Services
Based on technology, the genomics market is divided into:
- PCR
- Sequencing
- Microarray
- Nucleic Acid Extraction and Purification
- Others
The genomics market is segmented on the basis of application into:
- Diagnostics
- Drug Discovery and Development
- Precision Medicine
- Agriculture and Animal Research
- Others
Based on end-uses, the genomics market is divided into:
- Research Centres and Academic and Government Institutes
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Others
The EMR report looks into the regional genomics markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Genomics Market Analysis
The global genomics market is driven by the application of human genetic research in multiple government health programs such as consumer wellness programs, demographic screening, and others. The key objectives of the programs are to optimize preventive care for prevalent chronic diseases such as cancer and heart disease. The growing investment by government agencies, financing departments, and biotechnology firms to accelerate genomic research is expected to have significant implications for the genomics market reshaping. International financing agencies such as NIH and Welcome Trust are committed to offering to finance genetic research, which is supposed to boost genomic research in both advanced and emerging countries, further aiding the global genomics market.
Global Genomics Market: Competitive Landscape
The report presents a detailed analysis of the following key players in the global genomics market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Illumina, Inc. (NASDAQ: ILMN)
- Qiagen
- Eurofins Scientific
- Agilent Technologies, Inc.
- Oxford Nanopore Technologies
- F. Hoffmann-La Roche
- Bio-Rad Laboratories, Inc.
- BGI Group
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2016-2020 |
| Forecast Period | 2021-2026 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Technology, Application, End Use, Region |
| Breakup by Product | Consumables, Systems and Software, Services |
| Breakup by Technology | PCR, Sequencing, Microarray, Nucleic Acid Extraction and Purification, Others |
| Breakup by Application | Diagnostics, Drug Discovery and Development, Precision Medicine, Agriculture and Animal Research, Others |
| Breakup by End Use | Research Centres and Academic & Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Illumina, Inc. (NASDAQ: ILMN), Qiagen (NYSE: QGEN), Eurofins Scientific (EPA: ERF), Agilent Technologies, Inc. (NYSE: A), Oxford Nanopore Technologies, F. Hoffmann-La Roche (SWX: ROG), Bio-Rad Laboratories, Inc. (NYSE: BIO), BGI Group, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Key Questions Answered in the Global Genomics Market Report
- How has the global genomics market performed in the previous years (2016-2020)?
- What is the forecast assessment of the industry for 2021-2026?
- What are the major drivers in the historical (2016-2020) and forecast (2021-2026) periods?
- What are the major constraints in the historical (2016-2020) and forecast (2021-2026) periods?
- What are the major demand indicators of the global genomics market?
- What are the major price indicators of the global genomics market?
- What are the price trends in the global genomics market?
- What is the degree of competition in the global genomics market?
- What are the major events and developments taking place within the global genomics market?
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
1.1 Objectives of the Study
1.1.1 Research Objective
1.1.2 Key Findings of the Report
2 Research Methodology
2.1 Data Extraction
2.2 Data Corroboration
2.3 Market Structure
2.4 Assumptions
2.5 Market Models
3 Introduction
3.1 Market Outlook
3.2 Key Industry Trends
3.3 Market Scope and Segmentation
3.4 Additional Insights
4 Executive Summary
4.1 Key Market Developments
4.2 Market Analysis
4.3 Key Players
4.4 Market Revenue and Growth
5 Market Dynamics
5.1 Market Driver Analysis
5.2 Market Restraint Analysis
5.3 Industry Challenges
5.4 Industry Opportunities
6 Global Genomics Market Analysis
6.1 Global Genomics Historical Historical Market (2016-2020) & Forecast (2021-2026)
6.2 Global Genomics Market Breakup by Product
6.2.1 Consumables
6.2.2 Systems and Software
6.2.3 Services
6.3 Global Genomics Market Breakup by Product: Historical Market (2016-2020) & Forecast (2021-2026)
6.3.1 Consumables
6.3.2 Systems and Software
6.3.3 Services
6.4 Global Genomics Market Breakup by Technology
6.4.1 PCR
6.4.2 Sequencing
6.4.3 Microarray
6.4.4 Nucleic Acid Extraction and Purification
6.4.5 Others
6.5 Global Genomics Market Breakup by Technology: Historical Market (2016-2020) & Forecast (2021-2026)
6.5.1 PCR
6.5.2 Sequencing
6.5.3 Microarray
6.5.4 Nucleic Acid Extraction and Purification
6.5.5 Others
6.6 Global Genomics Market Breakup by Application
6.6.1 Diagnostics
6.6.2 Drug Discovery and Development
6.6.3 Precision Medicine
6.6.4 Agriculture and Animal Research
6.6.5 Others
6.7 Global Genomics Market Breakup by Application: Historical Market (2016-2020) & Forecast (2021-2026)
6.7.1 Diagnostics
6.7.2 Drug Discovery and Development
6.7.3 Precision Medicine
6.7.4 Agriculture and Animal Research
6.7.5 Others
6.8 Global Genomics Market Breakup by End Use
6.8.1 Research Centres and Academic & Government Institutes
6.8.2 Hospitals and Clinics
6.8.3 Pharmaceutical and Biotechnology Companies
6.8.4 Others
6.9 Global Genomics Market Breakup by End Use: Historical Market (2016-2020) & Forecast (2021-2026)
6.9.1 Research Centres and Academic and Government Institutes
6.9.2 Hospitals and Clinics
6.9.3 Pharmaceutical and Biotechnology Companies
6.9.4 Others
6.10 Global Genomics Market Breakup by Region
6.10.1 North America
6.10.1.1 United States of America
6.10.1.2 Canada
6.10.2 Europe
6.10.2.1 Germany
6.10.2.2 United Kingdom
6.10.2.3 France
6.10.2.4 Italy
6.10.2.5 Others
6.10.3 Asia Pacific
6.10.3.1 China
6.10.3.2 Japan
6.10.3.3 India
6.10.3.4 ASEAN
6.10.3.5 Others
6.10.4 Latin America
6.10.4.1 Brazil
6.10.4.2 Argentina
6.10.4.3 Mexico
6.10.4.4 Others
6.10.5 Middle East & Africa
6.10.5.1 Saudi Arabia
6.10.5.2 United Arab Emirates
6.10.5.3 Nigeria
6.10.5.4 South Africa
6.10.5.5 Others
6.11 Global Genomics Market Breakup by Region: Historical Market (2016-2020) & Forecast (2021-2026)
6.11.1 North America
6.11.1.1 United States of America
6.11.1.2 Canada
6.11.2 Europe
6.11.2.1 Germany
6.11.2.2 United Kingdom
6.11.2.3 France
6.11.2.4 Italy
6.11.2.5 Others
6.11.3 Asia Pacific
6.11.3.1 China
6.11.3.2 Japan
6.11.3.3 India
6.11.3.4 ASEAN
6.11.3.5 Others
6.11.4 Latin America
6.11.4.1 Brazil
6.11.4.2 Argentina
6.11.4.3 Mexico
6.11.4.4 Others
6.11.5 Middle East & Africa
6.11.5.1 Saudi Arabia
6.11.5.2 United Arab Emirates
6.11.5.3 Nigeria
6.11.5.4 South Africa
6.11.5.5 Others
7 SWOT Analysis
7.1 Overview
7.2 Strengths
7.3 Weaknesses
7.4 Opportunities
7.5 Threats
8 Porter’s Five Forces Analysis
8.1 Overview
8.2 Buyer’s Power
8.3 Supplier’s Power
8.4 New Entrants
8.5 Degree of Rivalry
8.6 Substitutes
9 Key Players & Company Profiles
9.1 Illumina, Inc. (NASDAQ: ILMN)
9.1.1 Company Overview
9.1.2 Financial Analysis
9.2 Qiagen (NYSE: QGEN)
9.2.1 Company Overview
9.2.2 Financial Analysis
9.3 Eurofins Scientific (EPA: ERF)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.4 Agilent Technologies, Inc. (NYSE: A)
9.4.1 Company Overview
9.4.2 Financial Analysis
9.5 Oxford Nanopore Technologies
9.5.1 Company Overview
9.5.2 Financial Analysis
9.6 F. Hoffmann-La Roche (SWX: ROG)
9.6.1 Company Overview
9.6.2 Financial Analysis
9.7 Bio-Rad Laboratories, Inc. (NYSE: BIO)
9.7.1 Company Overview
9.7.2 Financial Analysis
9.8 BGI Group
9.8.1 Company Overview
9.8.2 Financial Analysis
9.9 Others
10 Industry Events and Developments
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global liquid biopsy market stood at a value of around USD 1,250 million in 2020. The market is further expected to grow at a CAGR of 22% in the forecast period of 2021-2026 to attain a value of U...
The global mammography market attained a value of USD 1.85 billion in 2020, driven by the rising healthcare expenditures, a thriving healthcare market, and the demand for routine screening.
The North America COVID-19 diagnostics market is primarily being driven by the high number of COVID-19 positive cases, especially in the United States of America, which performed about 390 million tes...
The global COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in the United States of America, which had performed about 390 million tests for COVID-19 as of March ...
The Asia Pacific COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in India and China, which have performed around 234 million and 160 million tests, respectively,...
NEWSLETTER